Koc University Hospital
Istanbul, 34010, Turkey (Türkiye)
NCT Number: NCT05964803
The primary aim of this study is to learn whether the frequency of lower urinary tract symptoms differ between the males with seronegativity for HIV and males living with HIV.
Looking for future studies?
Notify Me18 year and older
Male
Observational
Istanbul, 34010, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MLWH and control groups were asked to complete the following questionnaires: International Consultation on Incontinence Questionnaire - Male Lower Urinary Tract Symptoms (ICIQ-MLUTS), ICIQ-Short Form (ICIQ-SF), International Prostate Symptom Score (IPSS), King's Healthcare Questionnaire (KHQ), 8-item Overactive Bladder Questionnaire (OAB-V8), Urogenital Distress Inventory 6 and 7 (UDI 6 and UDI 7).
Time frame: Day 1
International Consultation on Incontinence Questionnaire
Time frame: Day 1
Male Lower Urinary Tract Symptoms (ICIQ-MLUTS)
Time frame: Day 1
ICIQ-Short Form (ICIQ-SF)
Time frame: Day 1
International Prostate Symptom Score (IPSS)
Time frame: Day 1
King's Healthcare Questionnaire (KHQ)
Time frame: Day 1
8-item Overactive Bladder Questionnaire (OAB-V8)
Time frame: Day 1
Urogenital Distress Inventory 6 and 7 (UDI 6 and UDI 7).
Koç University
Other
Males Living With HIV and LUTS: A Case-control Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05829759
Behavior, Bisexuality
Atlanta, Georgia, United States
View Trial DetailsNCT04706624
Blood-Borne Infections, Chemically-Induced Disorders
Hanoi, Vietnam
View Trial DetailsNCT05571319
Blood-Borne Infections, Communicable Diseases
Cape Town, Western Cape, South Africa
View Trial DetailsNCT04383223
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Atlanta, Georgia, United States
View Trial Details